Abstract

Chronic Hepatitis D (CHD) is caused by co-infection with the hepatitis delta virus (HDV) of individuals with hepatitis B virus infection (HBV, CHB). It is considered the most severe form of viral hepatitis, promoting liver fibrosis, cirrhosis and hepatocellular carcinoma. Additionally, CHD has shown to cause worse patient related outcomes as compared to CHB alone. Until recently, only pegylated interferon based therapeutic schemes were available for treatment of CHD.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.